Skip to search.
 TSX Up 0.74% TSX Ventures Up 0.24%

Novavax, Inc. (NVAX)

-NasdaqGS
1.33 Dec 7, 4:00PM EST
|Pre-Market : 1.35 Up 0.02 (1.50%) 9:00AM EST - Nasdaq Real Time Price
Prev Close:1.33
Open:N/A
Bid:1.33 x 31900
Ask:1.35 x 2100
1y Target Est:3.50
Beta:2.12506
Earnings Date:Feb 27 - Mar 3 (Est.)
Day's Range:N/A - N/A
52wk Range:1.16 - 8.95
Volume:20,160
Avg Vol (3m):19,670,900
Market Cap:360.75M
P/E (ttm):N/A
EPS (ttm):-1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAX 0.00%360.75M
MRK165.59B
1N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.05
Quarterly EPS Est (Dec-16) :-0.23
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback